Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Novelion (NVLN.TO)

Novelion (NVLN.TO)

0.00
-0.00 (0.00%)
52 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY ON WEAKNESS

Novelion(NVLN.TO)

Oct 10, 2002
Product is starting to broaden itself. Be patient.
Photo of Richard StoneRichard StoneUnlock Rating
$12.16

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Sep 24, 2002
Not a fan of pharmaceuticals and this one is not the best.
Photo of David BurrowsDavid BurrowsUnlock Rating
$12.20

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Sep 23, 2002
Has run into problems with US health agencies getting them to pay for the product. Should do OK.
Photo of David BaskinDavid BaskinUnlock Rating
$12.00

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Sep 23, 2002
Limited pipeline. Trying to expand. Has limited downside, but not much upside either.
Photo of Mark Jackson, CFAMark Jackson, CFAUnlock Rating
$12.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Sep 19, 2002
They have $5 a share in cash. Good product.
Photo of John ZechnerJohn ZechnerUnlock Rating
$12.01

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Novelion(NVLN.TO)

Sep 04, 2002
Has only one product. If it drops to $12.10, sell.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$12.24

Stock price when the opinion was issued

biotechnologypharmaceutical
STRONG BUY

Novelion(NVLN.TO)

Aug 26, 2002
Should move up significantly in the next 12/18 months.
Photo of Mike WeirMike WeirUnlock Rating
$12.18

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Aug 22, 2002
Can't see any earnings. Could drop.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$13.07

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Aug 19, 2002
US Medicare is not recognizing it for health costs yet. They also need another product.
Photo of David BaskinDavid BaskinUnlock Rating
$12.10

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Aug 14, 2002
Likes the company. Has had a rough time.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$13.68

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Novelion(NVLN.TO)

Jul 24, 2002
Downside target was $15. Needs better earnings. If it goes over $18 it becomes speculative.
Photo of Ross HealyRoss HealyUnlock Rating
$16.13

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Jul 03, 2002
Sales are picking up. Good partner.
Photo of Mike WeirMike WeirUnlock Rating
$18.88

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Novelion(NVLN.TO)

Jun 05, 2002
Got preliminary approval in Europe on their drug. A one trick pony.
Photo of Ted MacklinTed MacklinUnlock Rating
$20.89

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Novelion(NVLN.TO)

Jun 03, 2002
Have received European approval on Visodine so prospects look good. Will stay volatile. Long term good.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$19.17

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

May 22, 2002
Good product but running into problems getting approval by medical insurance plans. Volatile.
Photo of Laura WallaceLaura WallaceUnlock Rating
$18.23

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 91 to 105 of 190 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video